2021. RFLSP.Russian.Finnish.Life.Science.Industry.EN

2.12 BIOPHARMOS
Company profile
BioPharmos Group is a leading European company in industrial
biotechnological cultivation of cells of rare medicinal plants.
The group's facilities are located in St. Petersburg (Russia) and
Kotka (Finland) and are certified according to international
quality standards ISO 9001:2015 and ISO 22000:2005 (HACCP).
The group's R&D center provides patenting, testing and
certification of products in the Russian Federation and the
European Union. The company is also a member of the Skolkovo
Innovation Center.
In 2012, BioPharmos Group was awarded the European Grand
Prize for Quality (Grand Prix Européen de la Qualité) in the
category "Leader in Biotechnology innovations application".
Products and services
The company produces original and generic drugs to combat the
following groups of diseases:
§ Meteorological dependence and cardiovascular diseases;
§ Complications during pregnancy;
§ Infection diseases and flu;
§ Metabolic disorders;
§ Dysfunctional changes in the female reproductive system
and others.
Key figures:
Founded: 15.12.2008
Turnover (2020): 4,985 mln. RUB
Employees (2020): 1
INN: 7802456930
Type of company: micro enterprise
Product code: 72.19 Scientific research and
development in natural and technical
sciences
Contact information:
Engels pr., 27 lit. Zh
194156 St. Petersburg, Russia
+7 (999) 044 68 63
info@bioconstructor.ru
https://bioconstructor.ru/
Contact person: Kotin Oleg – General
Director
100
RUSSIAN-FINNISH LIFE SCIENCE INDUSTRY
Research and export directory